Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts (NCT05617950) | Clinical Trial Compass
UnknownNot Applicable
Salicylic Acid Versus Cryotherapy for the Treatment of HPV1-induced Plantar Warts
174 participantsStarted 2022-11
Plain-language summary
To evaluate whether salicylic acid was superior to cryotherapy for plantar warts
Who can participate
Age range12 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with HPV1-induced plantar warts.
* Total number of warts is ≤5.
* Aged 12 years or older.
Exclusion Criteria:
* Patients are currently participating in another trial for the treatment of plantar warts.
* Patients had received two or more consecutive sessions of cryotherapy, with an interval of no more than 4 weeks (The history of salicylic acid treatment was not considered as criteria for exclusion because high concentration salicylic acid is not commercially available in Chinese mainland).
* Patients have taken immunosuppressant drugs (such as oral corticosteroids) during the past three months.
* Patients have impaired healing eg due to diabetes, vitamin A deficiency, hyperthyroidism and hypothyroidism.
* Patients have autoimmune diseases (such as systemic lupus erythematosus, dermatomyositis, scleroderma or other diseases).
* Patients are pregnant or ready for pregnancies or breast-feeding.
* Patients have cold intolerance (such as cold urticaria, cryoglobulinaemia, cold agglutinin syndrome or Raynaud's syndrome).
* Patients have local pain intolerance.
* Patients have local hypoesthesia.
* Patients are unable to tolerate salicylic acid or cryotherapy.
What they're measuring
1
cure rate at 12 weeks
Timeframe: 12 weeks since the initial treatment
Trial details
NCT IDNCT05617950
SponsorThe 306 Hospital of People's Liberation Army